Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature review.
Saved in:
| Title: | Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature review. |
|---|---|
| Authors: | Delgado D; Division of Cardiology and Transplant, UHN, Toronto, ON, Canada., Dabbous F; Data Analytics - Real World Evidence, Evidera, Bethesda, MD, USA., Shivappa N; Cardiovascular, Renal and Metabolism (CVRM) Evidence, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA. nitin.shivappa@astrazeneca.com., Mazhar F; Real-World Evidence, Data Analytics, Evidera, Stockholm, Sweden., Wittbrodt E; Cardiovascular, Renal and Metabolism (CVRM) Evidence, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA., Shridharmurthy D; Data Analytics - Real World Evidence, Evidera, Bethesda, MD, USA., Järbrink K; Cardiovascular, Renal and Metabolism (CVRM) Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden. |
| Source: | Orphanet journal of rare diseases [Orphanet J Rare Dis] 2025 Jan 16; Vol. 20 (1), pp. 29. Date of Electronic Publication: 2025 Jan 16. |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1172 (Electronic) Linking ISSN: 17501172 NLM ISO Abbreviation: Orphanet J Rare Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
